Search Results - "Eric P. Griggs"
-
1
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022
Published in MMWR. Morbidity and mortality weekly report (18-02-2022)“…CDC recommends that all persons aged ≥12 years receive a booster dose of COVID-19 mRNA vaccine ≥5 months after completion of a primary mRNA vaccination series…”
Get full text
Journal Article Newsletter -
2
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022
Published in MMWR. Morbidity and mortality weekly report (28-01-2022)“…Estimates of COVID-19 mRNA vaccine effectiveness (VE) have declined in recent months (1,2) because of waning vaccine induced immunity over time,* possible…”
Get full text
Journal Article Newsletter -
3
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With Coronavirus Disease 2019—VISION Network, 10 States, June 2021–March 2023
Published in Clinical infectious diseases (17-02-2024)“…Abstract Background The epidemiology of coronavirus disease 2019 (COVID-19) continues to develop with emerging variants, expanding population-level immunity,…”
Get full text
Journal Article -
4
Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021–2022 Season, VISION Network
Published in The Journal of infectious diseases (14-07-2023)“…Abstract Background Following historically low influenza activity during the 2020–2021 season, the United States saw an increase in influenza circulating…”
Get full text
Journal Article -
5
Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents
Published in Pediatrics (Evanston) (01-05-2023)“…We assessed BNT162b2 vaccine effectiveness (VE) against mild to moderate and severe coronavirus disease 2019 (COVID-19) in children and adolescents through the…”
Get full text
Journal Article -
6
Role of Age in the Spread of Influenza, 2011–2019: Data From the US Influenza Vaccine Effectiveness Network
Published in American journal of epidemiology (01-03-2022)“…Abstract Intraseason timing of influenza infection among persons of different ages could reflect relative contributions to propagation of seasonal epidemics…”
Get full text
Journal Article -
7
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19—VISION Network, August 2021 to March 2022
Published in The Journal of infectious diseases (18-04-2023)“…Abstract Background We assessed coronavirus disease 2019 (COVID-19) vaccination impact on illness severity among adults hospitalized with COVID-19, August…”
Get full text
Journal Article -
8
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023
Published in Clinical infectious diseases (17-02-2024)“…The epidemiology of coronavirus disease 2019 (COVID-19) continues to develop with emerging variants, expanding population-level immunity, and advances in…”
Get full text
Journal Article -
9
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19–Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions — VISION Network, September 2022–April 2023
Published in American journal of transplantation (01-07-2023)Get full text
Journal Article -
10
Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness
Published in Clinical infectious diseases (03-05-2023)“…Abstract Background Coronavirus disease 2019 (COVID-19) vaccination coverage remains lower in communities with higher social vulnerability. Factors such as…”
Get full text
Journal Article -
11
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022
Published in MMWR. Morbidity and mortality weekly report (04-03-2022)“…The efficacy of the BNT162b2 (Pfizer-BioNTech) vaccine against laboratory-confirmed COVID-19 exceeded 90% in clinical trials that included children and…”
Get full text
Journal Article Newsletter -
12
Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods
Published in JAMA network open (01-03-2023)“…Recent SARS-CoV-2 Omicron variant sublineages, including BA.4 and BA.5, may be associated with greater immune evasion and less protection against COVID-19…”
Get full text
Journal Article -
13
-
14
Vaccine Effectiveness Against SARS-CoV-2 Related Hospitalizations in People who had Experienced Homelessness or Incarceration – Findings from the Minnesota EHR Consortium
Published in Journal of community health (01-06-2024)“…COVID-19 disproportionately affects people experiencing homelessness or incarceration. While homelessness or incarceration alone may not impact vaccine…”
Get full text
Journal Article -
15
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022
Published in MMWR. Morbidity and mortality weekly report (30-12-2022)“…During June-October 2022, the SARS-CoV-2 Omicron BA.5 sublineage accounted for most of the sequenced viral genomes in the United States, with further Omicron…”
Get full text
Journal Article Newsletter -
16
Symptoms and recovery among adult outpatients with and without COVID‐19 at 11 healthcare facilities—July 2020, United States
Published in Influenza and other respiratory viruses (01-05-2021)“…Background Symptoms of mild COVID‐19 illness are non‐specific and may persist for prolonged periods. Effects on quality of life of persistent poor physical or…”
Get full text
Journal Article -
17
Risk of COVID‐19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric Disorders
Published in Influenza and other respiratory viruses (01-03-2024)“…ABSTRACT Background Although psychiatric disorders have been associated with reduced immune responses to other vaccines, it remains unknown whether they…”
Get full text
Journal Article -
18
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021
Published in MMWR. Morbidity and mortality weekly report (05-11-2021)“…Previous infection with SARS-CoV-2 (the virus that causes COVID-19) or COVID-19 vaccination can provide immunity and protection from subsequent SARS-CoV-2…”
Get full text
Journal Article Newsletter -
19
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023
Published in MMWR. Morbidity and mortality weekly report (26-05-2023)“…On September 1, 2022, CDC's Advisory Committee on Immunization Practices (ACIP) recommended a single bivalent mRNA COVID-19 booster dose for persons aged ≥12…”
Get full text
Journal Article Newsletter -
20
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022
Published in MMWR. Morbidity and mortality weekly report (21-10-2022)“…Persons with moderate-to-severe immunocompromising conditions might have reduced protection after COVID-19 vaccination, compared with persons without…”
Get full text
Journal Article Newsletter